Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$366M |
| 2 |
Wells Fargo
WFC
|
+$158M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$157M |
| 4 |
Dollar Tree
DLTR
|
+$151M |
| 5 |
Evergy
EVRG
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$229M |
| 2 |
Alcoa
AA
|
+$206M |
| 3 |
Visa
V
|
+$130M |
| 4 |
Darden Restaurants
DRI
|
+$127M |
| 5 |
Northern Trust
NTRS
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.41% |
| 2 | Consumer Discretionary | 13.39% |
| 3 | Technology | 10.01% |
| 4 | Real Estate | 8.2% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Service Corp International
SCI
$11.4B
| $18.9M | 0.09% |
527,326
+249,353
| +90% | +$9.24M |
|
|
ALXN
327
DELISTED
Alexion Pharmaceuticals
ALXN
| $18.8M | 0.09% |
151,068
-370,070
| -71% | -$43.3M |
|
328
Apple Hospitality REIT
APLE
$3.94B
| $18.7M | 0.09% |
1,048,504
+382,643
| +57% | +$6.99M |
|
|
329
Walt Disney
DIS
$186B
| $18.7M | 0.09% |
178,740
-2,237,631
| -93% | -$229M |
|
330
VanEck Oil Services ETF
OIH
$1.95B
| $18.7M | 0.08% |
35,595
+28,888
| +431% | +$15.5M |
|
331
iShares MSCI Emerging Markets ETF
EEM
$31.2B
| $18.6M | 0.08% |
430,113
+2,124
| +0.5% | +$98.3K |
|
332
PUT
Align Technology
ALGN
$11.5B
| $18.4M | 0.08% |
53,700
-113,600
| -68% | -$33.9M |
|
|
NEX
333
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $18.4M | 0.08% |
1,343,101
+1,313,859
| +4,493% | +$19.7M |
|
334
CALL
Eli Lilly
LLY
$1.12T
| $18.3M | 0.08% |
215,000
-122,500
| -36% | -$10.1M |
|
|
NVO
335
CALL
Novo Nordisk
NVO
$207B
| $18.2M | 0.08% |
+790,000
| New | +$18.8M |
|
336
NiSource
NI
$19.5B
| $18.2M | 0.08% |
+691,227
| New | +$16.9M |
|
337
Brighthouse Financial
BHF
$3.01B
| $18.1M | 0.08% |
+451,050
| New | +$21.7M |
|
|
NVO
338
Novo Nordisk
NVO
$207B
| $17.9M | 0.08% |
774,696
+181,136
| +31% | +$4.3M |
|
339
Mercado Libre
MELI
$97.5B
| $17.7M | 0.08% |
+59,257
| New | +$18.7M |
|
|
NATI
340
DELISTED
National Instruments Corp
NATI
| $17.6M | 0.08% |
420,143
+400,656
| +2,056% | +$17.8M |
|
341
T-Mobile US
TMUS
$196B
| $17.6M | 0.08% |
294,745
+219,807
| +293% | +$13M |
|
342
TransUnion
TRU
$16.2B
| $17.5M | 0.08% |
244,508
-46,311
| -16% | -$3.09M |
|
343
Bankunited
BKU
$3.3B
| $17.5M | 0.08% |
428,675
-486,474
| -53% | -$20.2M |
|
|
BDN
344
Brandywine Realty Trust
BDN
$522M
| $17.5M | 0.08% |
1,036,898
-448,300
| -30% | -$7.19M |
|
345
Manhattan Associates
MANH
$12.5B
| $17.4M | 0.08% |
371,108
+248,061
| +202% | +$11M |
|
|
CLVS
346
DELISTED
Clovis Oncology, Inc.
CLVS
| $17.3M | 0.08% |
380,313
-88,853
| -19% | -$4.32M |
|
347
G-III Apparel Group
GIII
$1.43B
| $17.3M | 0.08% |
389,317
-189,430
| -33% | -$7.7M |
|
|
QTS
348
DELISTED
QTS REALTY TRUST, INC.
QTS
| $17.2M | 0.08% |
434,821
-275,221
| -39% | -$10.2M |
|
349
Jazz Pharmaceuticals
JAZZ
$16.5B
| $17M | 0.08% |
98,816
-54,291
| -35% | -$8.87M |
|
350
State Street Financial Select Sector SPDR ETF
XLF
$56B
| $17M | 0.08% |
638,800
+418,800
| +190% | +$11.6M |
|
Similar funds
Dmitry Balyasny's Q2 2018 Portfolio in Review
As of Q2 2018, Dmitry Balyasny held 2,414 positions worth $22B, down 8% from $23.9B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dmitry Balyasny withdrew a net $2.72B in Q2 2018, closing 678 positions and reducing 664 holdings. Its most notable exit was Burlington, an estimated $114M position sold in full.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Dmitry Balyasny opened a new position in Evergy worth $156M.
- Dmitry Balyasny's largest Q2 2018 buy was Evergy: 2,779,050 shares worth $156M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $366M increase.
- Dmitry Balyasny's biggest Q2 2018 reduction was Walt Disney, cutting an estimated $229M.
- Dmitry Balyasny fully exited Burlington in Q2 2018, selling an estimated $114M.
- Dmitry Balyasny's ten largest holdings make up 11% of its $22B portfolio in Q2 2018.
- Dmitry Balyasny opened 528 new positions and closed 678 in Q2 2018.
- Dmitry Balyasny's portfolio value fell 8% quarter-over-quarter to $22B.
Based on Balyasny Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.